Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2004
04/01/2004WO2003050283A3 A structure for presenting desired peptide sequences
04/01/2004WO2003048770A3 Method for performing in vitro diagnosis using gene regulation mechanisms and corresponding diagnosis kit
04/01/2004WO2003046214A3 Method for analyzing translation-controlled gene expression
04/01/2004WO2003046201A3 Detection and identification of enteric bacteria
04/01/2004WO2003045990A3 Protein-protein interactions involving transforming growth factor beta signalling
04/01/2004WO2003040729A3 Method for identifying pathogenic particles in an organism
04/01/2004WO2003040670A3 Method of identifying energy transfer sensors for analytes
04/01/2004WO2003039703A3 Method in the form of a dry rapid test for detecting nucleic acids
04/01/2004WO2003038444A3 Biomarkers of liver function
04/01/2004WO2003034819A8 Nox software sensor
04/01/2004WO2003034064A3 Image analysis of high-density synthetic dna microarrays
04/01/2004WO2003031986A3 Application of the crystal structure of nusa in drug discovery
04/01/2004WO2003031940A3 Structural and cytoskeleton-associated proteins
04/01/2004WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein
04/01/2004WO2003028271A3 Methods of using quantitative lipid metabolome data
04/01/2004WO2003027328A3 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid
04/01/2004WO2003019141A3 Analysis of circulating tumor cells, fragments, and debris
04/01/2004WO2003012436A3 Method and system for predicting initial analyte values in stored samples
04/01/2004WO2003008440A3 Nucleic acid molecules encoding proteins essential for plant growth
04/01/2004WO2002097047A3 Compositions and methods for the inference of pigmentation traits
04/01/2004WO2002095417A3 PRE-mRNA SPLICING SCREENING ASSAY
04/01/2004WO2002095416A8 Method for identifying micro-organisms using mass spectrometry
04/01/2004WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit
04/01/2004WO2002077604A3 Labeled cells for use as an internal functional control in rare cell detection assays
04/01/2004WO2002077176A3 Aberrantly expressed proteins in laser capture microdissected tumors
04/01/2004WO2002077012A3 Human papilloma virus immunoreative peptides
04/01/2004WO2002076343A9 Method and kit for quantitation of histidine-tagged polypeptides
04/01/2004WO2002076203A9 Method and system for preparing tissue samples for histological and pathological examination
04/01/2004WO2002064631A3 T1r taste receptors and genes encoding same
04/01/2004WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
04/01/2004WO2001036671A3 A new method for the examination of protein localization in living cells
04/01/2004US20040064848 Comprises nucleotide sequences coding dehydroquinase/shikimate dehydrogenase for use in high throughput assay which detects herbicides
04/01/2004US20040064265 Assay methods for hydratable cementitious compositions
04/01/2004US20040064243 Vehicle-installed exhaust gas analyzing apparatus
04/01/2004US20040064068 Integrated lancet and bodily fluid sensor
04/01/2004US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/01/2004US20040063914 Antibodies against phosphorylated VASP ( vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
04/01/2004US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy
04/01/2004US20040063905 Armed peptides
04/01/2004US20040063742 Such as 5-(4-Chlorophenyl)-8-methyl-6,7,8,9-tetrahydro-1-H-pyrrolo(3.2-h)isoquinoline-2,3-dione-3-oxime-(phenyl))urea; kits; drug screening
04/01/2004US20040063735 Calcitonin gene related peptide receptor antagonists
04/01/2004US20040063636 Use of compounds for the regulation of food intake
04/01/2004US20040063627 Stabilizing dystrophin associated protein complexes; abnormal synapses or neuromuscular junction disorders
04/01/2004US20040063617 Expressing a nucleic acid encoding protein selected from lactoferrin protein and lysozyme protein in a monocot seed; isolating protein from the seed, combining with carrier diluent to provide formulation for oral administration
04/01/2004US20040063478 Withdrawal of samples
04/01/2004US20040063222 Method of assaying pyrrole-containing biological compounds
04/01/2004US20040063221 Method for producing arrays and devices relating thereto
04/01/2004US20040063220 Hydrophobic polymeric layer comprised of silanized scaffold for DNA and RNA diagnostics and analysis; detecting autoimmune diseases
04/01/2004US20040063219 Urine assay for ovarian reserve
04/01/2004US20040063218 Immunoassay device and method
04/01/2004US20040063215 Apparatus which utilizes electrical resistance for measuring and detecting integrated concentrations of hydrogen sulfide present in gas stream; emission testing of automobiles; pollution control
04/01/2004US20040063213 Pretreatment; using tetrazolium compound and polyoxyethylene glycol surfactant; accuracy measurement
04/01/2004US20040063212 Conditioning chamber for metallurgical surface science
04/01/2004US20040063211 Occult blood test enhancer
04/01/2004US20040063209 Apparatus for purging fluids from containers using position information; pollution control
04/01/2004US20040063198 Point source biological agent detection system
04/01/2004US20040063197 Apparatus which utilizes polymerase chain reactions to detect aerosolized biological agent in air and on abjects
04/01/2004US20040063196 Microfluidic apparatus for dielectric and optical manipulation of suspended particles, such as, proteins, DNA and cells
04/01/2004US20040063191 Compositions and methods for determining the replication capacity of a pathogenic virus
04/01/2004US20040063189 Bacteriophages that infect bacillus bacteria (anthrax)
04/01/2004US20040063187 Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of chromatography
04/01/2004US20040063178 Comprises enzymatic polypeptide for identifying modulators of leukocyte adhesion and treatments of inflammatory diseases l
04/01/2004US20040063168 System and method for analyzing antibiotic susceptibility of biological samples
04/01/2004US20040063165 Light-activated in vitro assay process for luciferase bioluminescence
04/01/2004US20040063164 Kit and method for detecting the esm-1 protein
04/01/2004US20040063163 Using ferromagnetic particles to generate magnetomotive forces in red blood cells without damaging surface for defining and classifying various blood groups prior to blood transfusion
04/01/2004US20040063162 Using fluorescent reporter molecules and optical analysis to identify cell undergoing cellular hypertrophy; drug design and screening; gene therapy
04/01/2004US20040063161 Compositions and method of treating Alzheimer's disease
04/01/2004US20040063160 Kit for rapid detection of viral particles and diagnosing viral diseases
04/01/2004US20040063159 Molecularly imprinted microspheres prepared using precipitation polymerisation
04/01/2004US20040063157 Pharmacophore recombination for the identification of small molecule drug lead compounds
04/01/2004US20040063156 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
04/01/2004US20040063153 Recovering natively configured polypeptides using spin columns comprising modified fragments of protein A reversibly bound to solid phase matrix
04/01/2004US20040063151 Method of performing gradient-based assays in a microfluidic device
04/01/2004US20040063149 Method of identifying abnormal immune reactions
04/01/2004US20040063148 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity
04/01/2004US20040063147 Novel applications of acridinium compounds and derivatives in homogeneous assays
04/01/2004US20040063146 Diffraction-based diagnostic devices
04/01/2004US20040063142 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
04/01/2004US20040063140 Methods for diagnosis of cancer using erbB-3
04/01/2004US20040063139 Comprises using nucleotide sequences coding deoxyguanosine triphosphate triphosphophydrolase to detect microorganisms in water supply
04/01/2004US20040063138 Polynucleotide sequencing method
04/01/2004US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery
04/01/2004US20040063131 Comprises neuroendocrine-specific proteins-like polypeptides (NSPLP) for diagnosis, prevention and treatment of neurodegenerative and cell proliferative diseases
04/01/2004US20040063126 Electrochemical sensor using intercalative, redox-active moieties
04/01/2004US20040063124 Methods and apparatus for preparing and assaying biological samples to determine protein concentration
04/01/2004US20040063120 Using tumor marker protein to diagnose and prognose cell proliferative disorders of respiratory system
04/01/2004US20040063118 Using two dimensional electrospray ionization tandem mass spectrometry (ESI/MS/MS) to analyze bodily fluid and determine lipid concentration for diagnosing risk of cardiovascular disorders and obesity
04/01/2004US20040063112 Using template to prepare imprinted frozen fluid usable as separation medium, recognition element in sensors and bioassays and as catalyst
04/01/2004US20040063111 Method for protecting personal information
04/01/2004US20040063109 Apparatus for monitoring allelic discrimination and/or gene expression analysis and subsequent storage on computer medium
04/01/2004US20040063101 Comprises nucleotide sequences coding cancer/testis (CT) antigen for diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy
04/01/2004US20040063100 Microinjection apparatus comprising plurality of shafts for transfer of bioparticles into cells
04/01/2004US20040063097 Nanomachine compositions and methods of use
04/01/2004US20040063092 Immunoassays for anti-HCV antibodies
04/01/2004US20040063090 Method for quantification of recombinant viruses
04/01/2004US20040063089 Device which utilizes optical analysis identify modulators of arrhythmia, hypertension and diabetes; drug screening
04/01/2004US20040063088 Analyzing effect of antitumor agents on tumorous breast tissue
04/01/2004US20040062854 Overcoating slide with polymer; immobilization
04/01/2004US20040062841 Food processing of dough; computer control